Non-prescription and compounded peptides such as BPC-157, CJC-1295/Ipamorelin, AOD-9604, and MOTS-c are not FDA-approved for weight loss and lack the same regulatory oversight and clinical safety data as the GLP-1 drugs in the table above, which is why they should only be used under the guidance of a licensed medical provider who can order lab work, personalize dosing, and monitor for side effects throughout treatment
The Good Life IV provides full mobile coverage with physician oversight, peptides, NAD+, and membership savings that bring premium care to this growing community for the first time
This was one of the first signals that the peptide wasn't just a wound-healing agent it had specific follicular activity
Many patients lose significant weight on an injectable GLP-1 but then struggle with what comes next
Necroptosis in development, inflammation and disease